Achillion Pharmaceuticals Cash and ST Investments: 65.14M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ACHN Cash and ST Investments Rankings
| Overall | 46th percentile | 2440 of 4527 |
| Sector | 55th percentile | 232 of 519 in Healthcare |
| Industry | 54th percentile | 74 of 163 in Biotechnology |
ACHN Cash and ST Investments Range, Past 5 Years
| Minimum | 9.58M | Dec 2005 |
| Maximum | 62.57M | Dec 2006 |
| Average |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these ACHN related companies
ACHN News
@collegefb81 $idix,$vvus,$achn we have some of the same stocks... Im holding for the conferences, if your scared high beta stocks will kill
about 2 days ago by GArgondizza
about 2 days ago by GArgondizza
RT @collegefb81 @GArgondizza im ah trying, we need some big news, majority of my $$ is in all these biotechs $DNDN $VVUS $ACHN $IDIX > $IBB
about 2 days ago by CashN1n9
about 2 days ago by CashN1n9
@GArgondizza im ah trying, we need some big news, majority of my $$ is in all these biotechs $DNDN $VVUS $ACHN $IDIX
about 2 days ago by collegefb81
about 2 days ago by collegefb81
added to $achn and $idix gotta hold them for the weekend just in case and gains coming wit the conferences next week anyway
about 2 days ago by mthester
about 2 days ago by mthester
$IDIX $ACHN $DNDN ... next week big conference, follow #BIOCEO2012, truck pulling back this week, action coming IMHO
about 2 days ago by littleguy
about 2 days ago by littleguy
$DNDN $IDIX $ACHN holding over the weekend I mean the conference is next week what a little more red right
about 2 days ago by odyssea
about 2 days ago by odyssea
$ACHN $IDIX, why the sell off? if any offers are made it usually happens over the weekend
about 2 days ago by 732allst
about 2 days ago by 732allst
crap, $ACHN selling off, maybe being put into some of our other favs....$VVUS $DNDN $IDIX ???
about 2 days ago by collegefb81
about 2 days ago by collegefb81
This week has wiped /all/ my 2012 gains, efff $IDIX, $ACHN . Out of the #BIOTECH game
about 2 days ago by fukuyama09
about 2 days ago by fukuyama09
is it this weekend that $ACHN gets the b/o offer? I cant remember what they said.
about 2 days ago by MovingRanger
about 2 days ago by MovingRanger
$ACHN made a run, now its turn for $ACHN's brother $VVUS and $IDIX to run
about 2 days ago by collegefb81
about 2 days ago by collegefb81
@collegefb81 I am holding 500 $IDIX & 500 $ACHN in my IRA come what may. Hep C deal gonna come sooner or later.
about 2 days ago by Rodg3r
about 2 days ago by Rodg3r
Morning Movers 02/07: (SATC) (BMTI) (CSTR) (MNI) Higher; (ASTX) (ACHN) (BVSN) Lower
Feb 07, 11:00AM Street Insider
Feb 07, 11:00AM Street Insider
UPDATE: Bank of America Downgrades Achillion Pharmaceuticals to Underperform
Feb 07, 7:16AM Benzinga
Feb 07, 7:16AM Benzinga
BofA/Merrill Lynch Downgrades Achillion Pharmaceuticals (ACHN) Two-Notches to Underperform
Feb 07, 6:55AM Street Insider
Feb 07, 6:55AM Street Insider
Unusual 11 Midday Movers 01/20: (INSM) (SCHS) (CPY) Higher; (NCIT) (CCOI) (THS) Lower
Jan 20, 1:43PM Street Insider
Jan 20, 1:43PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACHN | 9.89 | 0.42 | 4.49% | 689.88M |
| PG | 63.88 | -0.16 | -0.25% | 175.75B |
| AEP | 39.30 | -0.07 | -0.18% | 18.95B |
| DIT | 65.30 | 0.03 | 0.04% | 40.48M |
| LSI | 8.33 | 0.08 | 0.97% | 4.69B |
| SNE | 19.53 | -0.38 | -1.91% | 19.60B |
| CGA | 4.75 | 0.00 | 0.00% | 127.54M |
| DV | 38.56 | -0.28 | -0.72% | 2.59B |
| CRM | 128.44 | 2.83 | 2.25% | 17.40B |
| RUE | 26.23 | 0.15 | 0.58% | 641.59M |
